3b Blackbio Dx Ltd vs Aatmaj Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1296 as of 30 Oct 15:30 . The P/E Ratio of 3B Blackbio DX Ltd changed from 1.9 on March 2021 to 29 on March 2025 . This represents a CAGR of 72.48% over 5 yearsThe P/E Ratio of Aatmaj Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of 3B Blackbio DX Ltd changed from ₹ 213.76 crore on March 2021 to ₹ 1387 crore on March 2025 . This represents a CAGR of 45.37% over 5 yearsThe Market Cap of Aatmaj Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of 3B Blackbio DX Ltd for the Jun '26 is ₹ 39.63 crore as compare to the Mar '26 revenue of ₹ 45.58 crore. This represent the decline of -13.05% The revenue of Aatmaj Healthcare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of 3B Blackbio DX Ltd for the Jun '26 is ₹ 14.67 crore as compare to the Mar '26 ebitda of ₹ 18.64 crore. This represent the decline of -21.3% The ebitda of Aatmaj Healthcare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of 3B Blackbio DX Ltd changed from ₹ 11.3 crore to ₹ 8.98 crore over 9 quarters. This represents a CAGR of -9.71% The net profit of Aatmaj Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of 3B Blackbio DX Ltd changed from 391.92 % on March 2021 to 8.69 % on March 2026 . This represents a CAGR of -47.00% over 6 yearsThe Dividend Payout of Aatmaj Healthcare Ltd changed from 12.84 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 years .

About 3B Blackbio DX Ltd

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies.
Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions.

About Aatmaj Healthcare Ltd

Aatmaj Healthcare Limited was originally incorporated under the name Aatmaj Healthcare Private Limited' on March 10, 2014 issued by the RoC, Gujarat.
Thereafter, the Company was converted to Public Limited Company and name of the Company was changed to Aatmaj Healthcare Limited' vide fresh Certificate of Incorporation dated December 06, 2022.
The Company is a rapidly growing organization to establish itself as a leading healthcare provider, utilizing modern medicinal practices and advanced infrastructure for medical and surgical care solutions. The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services.
The main activities of the Company include operation of multidisciplinary private hospitals and clinics.
The healthcare facilities consist of advanced technology and doctors, nurses and other healthcare professionals follow treatment protocols that match acceptable standards.

FAQs for the comparison of 3B Blackbio DX Ltd and Aatmaj Healthcare Ltd

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Aatmaj Healthcare Ltd?

Market cap of 3B Blackbio DX Ltd is 1,112 Cr while Market cap of Aatmaj Healthcare Ltd is 53 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Aatmaj Healthcare Ltd?

The stock performance of 3B Blackbio DX Ltd and Aatmaj Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Aatmaj Healthcare Ltd?

As of October 31, 2026, the 3B Blackbio DX Ltd stock price is INR ₹1296.25. On the other hand, Aatmaj Healthcare Ltd stock price is INR ₹23.8.

How do dividend payouts of 3B Blackbio DX Ltd and Aatmaj Healthcare Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Aatmaj Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.